![](https://www.signifyresearch.net/wp-content/uploads/2024/07/SPI-MI-Trivitrons-Terrene-CT-wp-564x420.jpg)
Written by
![Phil Grainger headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Phil-Grainger-150x150.jpg)
Phil Grainger
![Bhvita Jani headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Signify-Bhvita_J-Profile-@2-150x150.png)
Bhvita Jani
Trivitron Healthcare announced the launch of its Terrene CT scanner in early July, highlighting that the system is the first of its kind in India to receive approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB) and Central Drugs Standard Control Organisation (CDSCO). The vendor boasts that the rigorous testing required to gain these approvals confirms the scanner’s exceptional quality, safety, and reliability.
Will India’s continuing efforts and incentives to prioritise domestic production of medical imaging devices be enough to allow Trivitron to carve out a place in the country’s CT market?
Read the full insight with a Signify Premium Insights - Medical Imaging subscription